Search - tctmd.com

Displaying 441 - 460 of 475

Sort: Relevancy | Date

Presentation TCT 2014

How to Achieve BRS Distal Delivery Through Tortuous Calcified Lesions

Presenter: Antonio Colombo, Nicolas M. van Mieghem, Giulio G. Stefanini

September 14, 2014

Presentation TCT 2014

Case #4: BRS in a Complex Bifurcation

Presenter: Antonio Colombo, Nicolas M. van Mieghem, Robert-Jan van Geuns

September 14, 2014

Presentation TCT 2014

BRS in Bifurcations: Basic Approach

Presenter: Antonio Colombo, Nicolas M. van Mieghem, Vladimir Dzavik

September 14, 2014

Presentation TCT 2014

Case #3: Implantation of Multiple Contiguous Scaffolds for Diffuse Disease

Presenter: Antonio Colombo, Nicolas M. van Mieghem, Christoph K. Naber

September 14, 2014

Presentation TCT 2014

Long Lesions: How to Implant Multiple Contiguous Scaffolds

Presenter: Antonio Colombo, Nicolas M. van Mieghem, Pieter C. Smits

September 14, 2014

Presentation TCT 2014

Case #2: BRS Sizing in Complex Disease

Presenter: Antonio Colombo, Nicolas M. van Mieghem, Tommaso Gori

September 14, 2014

Presentation TCT 2014

How to Size BRS (and Why This Is Different Than Metallic DES)

Presenter: Antonio Colombo, Nicolas M. van Mieghem, Tommaso Gori

September 14, 2014

Presentation TCT 2014

Case #1: BRS Optimal Lesion Preparation

Presenter: Antonio Colombo, Nicolas M. van Mieghem, Takeshi Kimura

September 14, 2014

Presentation TCT 2014

Why Optimal Lesion Preparation for BRS Is Critical and How to Achieve It

Presenter: Antonio Colombo, Nicolas M. van Mieghem, Dean J. Kereiakes

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

Presentation TCT 2014

Bioresorbable Scaffolds: Status Update and Potential Role in Femoropopliteal Disease

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon, Mahmood K. Razavi

September 13, 2014

Presentation TCT 2013

Perspectives on Bioresorbable Scaffolds: Establishing the Benefits of a Breakthrough Technology

Presenter: Stephan Windecker

October 31, 2013

Presentation TCT 2013

Case 2: How to Overlap Bioresorbable Scaffolds

Presenter: Jose Costa Jr

October 31, 2013

Presentation TCT 2013

Tips and Tricks to Deploy Bioresorbable Scaffolds

Presenter: Alexandre Abizaid

October 31, 2013

Presentation TCT 2013

Bioresorbable Vascular Scaffolds and Drug-Eluting Balloons: Which Subsets Meaningfully Benefit Beyond Metallic DES?

Presenter: Patrick Serruys

October 31, 2013

News Conference News TCT 2013

Vasim Farooq, MD, Wins Linnemeier Young Investigator Award

October 31, 2013

Presentation TCT 2013

Should Innovative New Device Platforms (Like Bioresorbable Scaffolds) Be Studied Using Global All-Comer "Big Data" Clinical Trials Rather Than Smaller Indication-Focused RCTs?

Presenter: Mitchell Krucoff

October 30, 2013

Presentation TCT 2013

Rationale for Bioresorbable Vascular Scaffolds as a VP Shield: The PROSPECT ABSORB Trial

Presenter: Gregg Stone

October 30, 2013

Presentation TCT 2013

Are There "Special" Device Approval Considerations (Preclinical and Clinical) for Bioresorbable vs. Metallic Scaffolds?

Presenter: Melissa Torres

October 30, 2013

Presentation TCT 2013

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Presenter: Takashi Muramatsu

October 29, 2013

Advertisement

How to Achieve BRS Distal Delivery Through Tortuous Calcified Lesions

Case #4: BRS in a Complex Bifurcation

BRS in Bifurcations: Basic Approach

Case #3: Implantation of Multiple Contiguous Scaffolds for Diffuse Disease

Long Lesions: How to Implant Multiple Contiguous Scaffolds

Case #2: BRS Sizing in Complex Disease

How to Size BRS (and Why This Is Different Than Metallic DES)

Case #1: BRS Optimal Lesion Preparation

Why Optimal Lesion Preparation for BRS Is Critical and How to Achieve It

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Bioresorbable Scaffolds: Status Update and Potential Role in Femoropopliteal Disease

Perspectives on Bioresorbable Scaffolds: Establishing the Benefits of a Breakthrough Technology

Case 2: How to Overlap Bioresorbable Scaffolds

Tips and Tricks to Deploy Bioresorbable Scaffolds

Bioresorbable Vascular Scaffolds and Drug-Eluting Balloons: Which Subsets Meaningfully Benefit Beyond Metallic DES?

Vasim Farooq, MD, Wins Linnemeier Young Investigator Award

Should Innovative New Device Platforms (Like Bioresorbable Scaffolds) Be Studied Using Global All-Comer "Big Data" Clinical Trials Rather Than Smaller Indication-Focused RCTs?

Rationale for Bioresorbable Vascular Scaffolds as a VP Shield: The PROSPECT ABSORB Trial

Are There "Special" Device Approval Considerations (Preclinical and Clinical) for Bioresorbable vs. Metallic Scaffolds?

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content